Lbmc Investment Advisors, LLC Provectus Biopharmaceuticals, Inc. Transaction History
Lbmc Investment Advisors, LLC
- $1.15 Billion
- Q2 2024
A detailed history of Lbmc Investment Advisors, LLC transactions in Provectus Biopharmaceuticals, Inc. stock. As of the latest transaction made, Lbmc Investment Advisors, LLC holds 22,000 shares of PVCT stock, worth $2,200. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,000
Previous 22,000
-0.0%
Holding current value
$2,200
Previous $3,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding PVCT
# of Institutions
7Shares Held
229KCall Options Held
0Put Options Held
0-
Home Federal Bank Of Tennessee100KShares$10,0000.0% of portfolio
-
Lee Danner & Bass Inc50KShares$5,0000.0% of portfolio
-
Atlas Wealth LLC Cincinnati, OH26.6KShares$2,6620.0% of portfolio
-
Academy Capital Management Inc Waco, TX20KShares$2,0000.0% of portfolio
-
Financial Symmetry Inc Raleigh, NC10.2KShares$1,0190.0% of portfolio
About PROVECTUS BIOPHARMACEUTICALS, INC.
- Ticker PVCT
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 419,496,992
- Market Cap $41.9M
- Description
- Provectus Biopharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing immunotherapy medicines based on halogenated xanthenes. It develops PV-10, an investigational autolytic cancer immunotherapy for adult solid tumor cancers, such as melanoma and gastrointestinal tumors, including hepatocellular carcinoma; colorectal ...